Literature DB >> 6166048

Raynaud syndrome.

R J Blunt, J M Porter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6166048     DOI: 10.1016/0049-0172(81)90006-8

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


× No keyword cloud information.
  17 in total

1.  [Not Available].

Authors:  L Latulippe
Journal:  Can Fam Physician       Date:  1983-02       Impact factor: 3.275

2.  Ketanserin in the treatment of traumatic vasospastic disease.

Authors:  V H Larsen; J Fabricius; G Nielsen; K S Hansen
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-13

3.  Aesthesiometric threshold changes over the course of a workshift in miners exposed to hand-arm vibration.

Authors:  T Haines; J Chong; A B Verrall; J Julian; C Bernholz; R Spears; D C Muir
Journal:  Br J Ind Med       Date:  1988-02

4.  Circulating lupus type anticoagulant and pulmonary hypertension associated with mixed connective tissue disease.

Authors:  P Hainaut; E Lavenne; J M Magy; E G Lebacq
Journal:  Clin Rheumatol       Date:  1986-01       Impact factor: 2.980

5.  Raynaud's syndrome and carpal tunnel syndrome.

Authors:  D G Waller; J R Dathan
Journal:  Postgrad Med J       Date:  1985-02       Impact factor: 2.401

Review 6.  Calcium antagonists in cerebral/peripheral vascular disorders. Current status.

Authors:  K J Tietze; M L Schwartz; P H Vlasses
Journal:  Drugs       Date:  1987-06       Impact factor: 9.546

7.  Vasodilators: minoxidil and drugs used in peripheral vascular and cerebral disorders.

Authors:  G D Lowe
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-16

8.  Clinical and laboratory effects of nifedipine in Raynaud's phenomenon.

Authors:  S J Hawkins; C M Black; N D Hall; A McGregor; E F Ring; P J Maddison
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

9.  Clinical and rheological effects of nifedipine in Raynaud's phenomenon.

Authors:  D G Waller; V F Challenor; D A Francis; O S Roath
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

10.  Prostaglandin E1 vasospastic disease and thermography.

Authors:  V Kyle; G Parr; R Salisbury; P P Thomas; B Hazleman
Journal:  Ann Rheum Dis       Date:  1985-02       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.